newsfilter
← Latest News
Business Wire·

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

New NeXT Personal® extension empowers clinicians to identify emerging resistance and therapeutically targetable mutations during disease monitoring and surveillance Personalis, Inc. (NASDAQ:PSNL), a leader in